These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7263847)

  • 21. Comparison between the plasma concentrations of prolactin and parathyroid hormone in normal subjects and in patients with hyperparathyroidism or hyperprolactinemia.
    Raymond JP; Isaac R; Merceron RE; Wahbe F
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1222-5. PubMed ID: 7130342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism.
    Neer RM; Tregear GW; Potts JT
    J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin response to N3im-methyl-thyrotropin releasing hormone in euthyroid subjects.
    Sowers JR; Hershman JM; Carlson HE; Pekary E; Nair MG; Baugh CM
    J Clin Endocrinol Metab; 1976 Oct; 43(4):749-55. PubMed ID: 824297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of H2 blockers on blood levels of parathormones and calcitonin in normal subjects].
    Biagi P; Galli M; Brettoni A
    Minerva Med; 1985 Oct; 76(38):1745-50. PubMed ID: 2864665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of parathyroid hormone (1-84) whole molecule and parathyroid hormone (7-84)-like fragments in pseudohypoparathyroidism type I.
    Hatakeyama Y; Mizunashi K; Furukawa Y; Yabuki S; Sato Y; Igarashi T
    J Clin Endocrinol Metab; 2003 May; 88(5):2250-5. PubMed ID: 12727982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of disodium EDTA and calcium infusion on prolactin and thyrotropin responses to thyrotropin-releasing hormone in healthy man.
    Dudczak R; Waldhäusl WK; Bratusch-Marrain P
    J Clin Endocrinol Metab; 1983 Mar; 56(3):603-7. PubMed ID: 6401762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Physiopathological aspects of the parathyroid hormone and calcitonin in childhood].
    Tanas R; Turchi S; Platé L; Ciacci L; Ventura D; Pirazzoli P; Cicognani A; Capelli M; Cacciari E
    Minerva Pediatr; 1979 Dec; 31(23):1669-76. PubMed ID: 233430
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma cyclic nucleotide determination in the investigation of hypocalcemia.
    Mallet E; Basuyau JP; Brunelle P; de Menibus CH
    Pediatr Res; 1979 May; 13(5 Pt 1):647-8. PubMed ID: 224372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of pseudo- and idiopathic hypoparathyroidism by measuring urinary calcitonin.
    Morimoto S; Onishi T; Kumahara Y; Avioli L
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1216-20. PubMed ID: 6630414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple abnormalities of anterior pituitary hormone secretion in association with pseudohypoparathyroidism.
    Shapiro MS; Bernheim J; Gutman A; Arber I; Spitz IM
    J Clin Endocrinol Metab; 1980 Sep; 51(3):483-7. PubMed ID: 6773975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum intact parathyroid hormone concentration measured by a two-site immunoradiometric assay in normal subjects and patients with various parathyroid disorders.
    Okazaki R; Matsumoto T; Furukawa Y; Fujimoto Y; Niimi H; Seino Y; Fujita T; Nagataki S; Ogata E
    Endocrinol Jpn; 1992 Feb; 39(1):115-20. PubMed ID: 1606913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
    Spencer CA; Greenstadt MA; Wheeler WS; Kletzky OA; Nicoloff JT
    J Clin Endocrinol Metab; 1980 Oct; 51(4):771-5. PubMed ID: 6774994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cytochemical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type I.
    Loveridge N; Fischer JA; Nagant de Deuxchaisnes C; Dambacher MA; Tschopp F; Werder E; Devogelaer JP; de Meyer R; Bitensky L; Chayen J
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1274-5. PubMed ID: 7076801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical heterogeneity of pseudohypoparathyroidism: from hyper- to hypocalcemia.
    Shalitin S; Davidovits M; Lazar L; Weintrob N
    Horm Res; 2008; 70(3):137-44. PubMed ID: 18663313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
    Shah GV; Wang W; Grosvenor CE; Crowley WR
    Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat.
    Harris AR; Christianson D; Smith MS; Fang SL; Braverman LE; Vagenakis AG
    J Clin Invest; 1978 Feb; 61(2):441-8. PubMed ID: 413840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new technic to evaluate the sensitivity of the renal parathyroid hormone receptor in man].
    Mallet E; de Menibus CH; Basuyau JP; Brunelle P
    C R Seances Soc Biol Fil; 1976; 170(5):1094-8. PubMed ID: 192424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the prolactin response to thyrotropin-releasing hormone (TRH) during the menstrual cycle of normal women.
    Boyd AE; Sanchez-Franco F
    J Clin Endocrinol Metab; 1977 May; 44(5):985-9. PubMed ID: 404311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1994 Jun; 54(6):473-6. PubMed ID: 8082049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.